Curis Inc Stock Today

CRIS Stock  USD 2.84  0.21  7.98%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Very High

 
High
 
Low
Curis is selling for under 2.84 as of the 16th of March 2025; that is 7.98 percent increase since the beginning of the trading day. The stock's lowest day price was 2.75. Curis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of August 2000
Category
Healthcare
Classification
Health Care
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Curis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 8.47 M outstanding shares of which 160.75 K shares are currently shorted by private and institutional investors with about 5.21 trading days to cover. More on Curis Inc

Moving together with Curis Stock

  0.68VRCA Verrica PharmaceuticalsPairCorr

Moving against Curis Stock

  0.49IVA Inventiva SaPairCorr
  0.4LLY Eli LillyPairCorr
  0.36PBH Prestige Brand HoldingsPairCorr

Curis Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Thematic IdeaCancer Fighters (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.190.15
Significantly Up
Pretty Stable
Gross Profit Margin0.930.88
Notably Up
Slightly volatile
Total Current Liabilities8.6 M15.5 M
Way Down
Slightly volatile
Non Current Liabilities Total27.6 M50.7 M
Way Down
Slightly volatile
Total Assets85.8 M88.9 M
Sufficiently Down
Slightly volatile
Total Current Assets64.2 M70 M
Significantly Down
Slightly volatile
Debt Levels
Curis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Curis' financial leverage. It provides some insight into what part of Curis' total assets is financed by creditors.
Liquidity
Curis Inc currently holds 2.79 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Curis Inc has a current ratio of 7.54, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Curis' use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

(32.86 Million)
Curis Inc (CRIS) is traded on NASDAQ Exchange in USA. It is located in Building C, Lexington, MA, United States, 02421 and employs 49 people. Curis is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.05 M. Curis Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 8.47 M outstanding shares of which 160.75 K shares are currently shorted by private and institutional investors with about 5.21 trading days to cover. Curis Inc currently holds about 98.69 M in cash with (38.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
Check Curis Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Curis Inc is $24.05 Million. 30% of Curis Inc outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Curis Ownership Details

Curis Stock Institutional Holders

InstituionRecorded OnShares
Blackrock Inc2024-12-31
68.3 K
Focused Wealth Strategies, Inc.2024-12-31
59.2 K
Northern Trust Corp2024-12-31
47.4 K
Millennium Management Llc2024-12-31
25.6 K
Engineers Gate Manager Lp2024-12-31
21.4 K
State Street Corp2024-12-31
21 K
Franklin Street Advisors Inc.2024-12-31
20 K
A16z Perennial Management Lp2024-12-31
13.3 K
Squarepoint Ops Llc2024-12-31
11.6 K
Maverick Capital Ltd2024-12-31
631.8 K
M28 Capital Management Lp2024-12-31
521.1 K
View Curis Diagnostics

Curis Historical Income Statement

At this time, Curis' Gross Profit is comparatively stable compared to the past year. Research Development is likely to gain to about 47.7 M in 2025, whereas Interest Expense is likely to drop slightly above 2.1 M in 2025. View More Fundamentals

Curis Stock Against Markets

Curis Corporate Management

Jonathan ZungChief OfficerProfile
Nancy SoohooVice CounselProfile
Reinhard MDSenior DevelopmentProfile
Elif McDonaldVP CommunicationsProfile
Mark NoelVice PropertyProfile
Rachel BlasbalgSenior ResourcesProfile

Additional Tools for Curis Stock Analysis

When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.